Liu, L.; Patnana, P.K.; Xie, X.; Frank, D.; Nimmagadda, S.C.; Rosemann, A.; Liebmann, M.; Klotz, L.; Opalka, B.; Khandanpour, C.
High Metabolic Dependence on Oxidative Phosphorylation Drives Sensitivity to Metformin Treatment in MLL/AF9 Acute Myeloid Leukemia. Cancers 2022, 14, 486.
https://doi.org/10.3390/cancers14030486
AMA Style
Liu L, Patnana PK, Xie X, Frank D, Nimmagadda SC, Rosemann A, Liebmann M, Klotz L, Opalka B, Khandanpour C.
High Metabolic Dependence on Oxidative Phosphorylation Drives Sensitivity to Metformin Treatment in MLL/AF9 Acute Myeloid Leukemia. Cancers. 2022; 14(3):486.
https://doi.org/10.3390/cancers14030486
Chicago/Turabian Style
Liu, Longlong, Pradeep Kumar Patnana, Xiaoqing Xie, Daria Frank, Subbaiah Chary Nimmagadda, Annegret Rosemann, Marie Liebmann, Luisa Klotz, Bertram Opalka, and Cyrus Khandanpour.
2022. "High Metabolic Dependence on Oxidative Phosphorylation Drives Sensitivity to Metformin Treatment in MLL/AF9 Acute Myeloid Leukemia" Cancers 14, no. 3: 486.
https://doi.org/10.3390/cancers14030486
APA Style
Liu, L., Patnana, P. K., Xie, X., Frank, D., Nimmagadda, S. C., Rosemann, A., Liebmann, M., Klotz, L., Opalka, B., & Khandanpour, C.
(2022). High Metabolic Dependence on Oxidative Phosphorylation Drives Sensitivity to Metformin Treatment in MLL/AF9 Acute Myeloid Leukemia. Cancers, 14(3), 486.
https://doi.org/10.3390/cancers14030486
